BONE ABSORPTIOMETRY IN METABOLIC BONE-DISEASE - BASE-LINE VALUES AND LONG-TERM TREATMENT WITH CALCITRIOL (POSTMENOPAUSAL OSTEOPOROSIS VERSUS OSTEOMALACIA)

Citation
A. Caniggia et B. Frediani, BONE ABSORPTIOMETRY IN METABOLIC BONE-DISEASE - BASE-LINE VALUES AND LONG-TERM TREATMENT WITH CALCITRIOL (POSTMENOPAUSAL OSTEOPOROSIS VERSUS OSTEOMALACIA), Cells and materials, 5(2), 1995, pp. 139-148
Citations number
37
Categorie Soggetti
Cell Biology","Medicine, Research & Experimental","Materials Science, Biomaterials
Journal title
ISSN journal
10516794
Volume
5
Issue
2
Year of publication
1995
Pages
139 - 148
Database
ISI
SICI code
1051-6794(1995)5:2<139:BAIMB->2.0.ZU;2-J
Abstract
Total body bone absorptiometry reveals low mineral density in both pos tmenopausal osteoporosis and osteomalacia patients. The method was use d to investigate the effect of calcitriol administration on patients s uffering from one of these conditions. In osteomalacia, the administra tion of calcitriol resulted in a dramatic improvement in bone mineral density (sometimes up to 50% in 12 months), indicating the rapid miner alization of previously uncalcified bone tissue as a result of the nor malization of the Ca x P product. In osteoporosis a similar treatment was seen to halt the progressive decrease in bone mineral levels and s ometimes resulted in minor increases in density (up to 5%). This is li kely to be due to a normalization of intestinal calcium malabsorption which halts secondary homeostatic bone resorption.